Comparison between antineoplastic treatments with selective inhibitors (BRAF/MEK) and the new potentials combinatorial therapies for metastatic melanoma. RSD [Internet]. 2022 Oct. 28 [cited 2025 Dec. 5];11(14):e326111436275. Available from: https://rsdjournal.org/rsd/article/view/36275